We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.7B
AUM Growth
+$28.1B
Cap. Flow
+$27.7B
Cap. Flow %
35.64%
Top 10 Hldgs %
8.03%
Holding
3,834
New
1,974
Increased
1,386
Reduced
336
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Financials 14.9%
3 Industrials 12.22%
4 Consumer Discretionary 10.07%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORBC
2551
DELISTED
ORBCOMM, Inc.
ORBC
$64K ﹤0.01%
+13,481
New +$80.6K
CPRI icon
2552
Capri Holdings
CPRI
$1.74B
$63K ﹤0.01%
1,896
-284
-13% -$9.1K
PLMR icon
2553
Palomar
PLMR
$3.45B
$63K ﹤0.01%
+1,606
New +$50.1K
RAD
2554
DELISTED
Rite Aid Corporation
RAD
$63K ﹤0.01%
+9,123
New +$65.5K
CRD.A icon
2555
Crawford & Co Class A
CRD.A
$669M
$62K ﹤0.01%
5,701
IIIN icon
2556
Insteel Industries
IIIN
$625M
$62K ﹤0.01%
+3,016
New +$60K
KE
2557
Kimball Electronics
KE
$628M
$62K ﹤0.01%
+4,302
New +$63.8K
PBYI icon
2558
Puma Biotechnology
PBYI
$454M
$62K ﹤0.01%
+5,770
New +$62.3K
RDWR icon
2559
Radware
RDWR
$1.19B
$62K ﹤0.01%
+2,550
New +$63.7K
WLDN icon
2560
Willdan Group
WLDN
$1.3B
$62K ﹤0.01%
+1,763
New +$62.9K
BKCC
2561
DELISTED
BlackRock Capital Investment Corporation
BKCC
$62K ﹤0.01%
+12,395
New +$68.4K
FLXN
2562
DELISTED
Flexion Therapeutics, Inc.
FLXN
$62K ﹤0.01%
+4,515
New +$53.6K
BDSI
2563
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$62K ﹤0.01%
+14,637
New +$62.5K
IMGN
2564
DELISTED
Immunogen Inc
IMGN
$61K ﹤0.01%
+25,037
New +$66.5K
AKRX
2565
DELISTED
Akorn Inc
AKRX
$61K ﹤0.01%
+16,089
New +$57.5K
AKRO
2566
DELISTED
Akero Therapeutics
AKRO
$60K ﹤0.01%
2,629
+1,021
+63% +$23.8K
CSWC icon
2567
Capital Southwest
CSWC
$1.6B
$60K ﹤0.01%
+2,742
New +$59.1K
CZNC icon
2568
Citizens & Northern Corp
CZNC
$455M
$60K ﹤0.01%
+2,270
New +$56.7K
DRRX
2569
DELISTED
DURECT Corp
DRRX
$60K ﹤0.01%
+3,274
New +$44.3K
FC icon
2570
Franklin Covey
FC
$246M
$60K ﹤0.01%
+1,710
New +$61.7K
KRYS icon
2571
Krystal Biotech
KRYS
$9.66B
$60K ﹤0.01%
+1,739
New +$77.7K
ORC
2572
Orchid Island Capital
ORC
$1.31B
$60K ﹤0.01%
+2,079
New +$63.1K
REAL icon
2573
The RealReal
REAL
$1.5B
$60K ﹤0.01%
+2,675
New +$53.8K
RYTM icon
2574
Rhythm Pharmaceuticals
RYTM
$7.96B
$60K ﹤0.01%
+2,790
New +$59.9K
TVTX icon
2575
Travere Therapeutics
TVTX
$5.78B
$60K ﹤0.01%
+5,149
New +$85.1K

Similar funds

Victory Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Victory Capital Management held 3,834 positions worth $77.7B, up 57% from $49.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Victory Capital Management deployed $27.7B of net new capital in Q3 2019, opening 1,974 new positions and adding to 1,386 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $98.7M trimmed.

  • Victory Capital Management's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.
  • Victory Capital Management added most to Microsoft in Q3 2019, an estimated $891M increase.
  • Victory Capital Management's biggest Q3 2019 reduction was Reliance Steel & Aluminium, cutting an estimated $98.7M.
  • Victory Capital Management fully exited Electronics for Imaging in Q3 2019, selling an estimated $61.5M.
  • Victory Capital Management's ten largest holdings make up 8% of its $77.7B portfolio in Q3 2019.
  • Victory Capital Management opened 1,974 new positions and closed 47 in Q3 2019.
  • Victory Capital Management's portfolio value rose 57% quarter-over-quarter to $77.7B.

Based on Victory Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.